about
Long-term follow-up of cancer patients treated with gene therapy medicinal products.Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union.Challenges with advanced therapy medicinal products and how to meet them.ATMPs for Cancer Immunotherapy: A Regulatory Overview
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria Cristina Galli
@en
Maria Cristina Galli
@nl
type
label
Maria Cristina Galli
@en
Maria Cristina Galli
@nl
prefLabel
Maria Cristina Galli
@en
Maria Cristina Galli
@nl
P31
P496
0000-0003-3538-6962